The Duffy Antigen/Receptor for Chemokines (DARC) and Prostate-Cancer Risk among Jamaican Men

被引：0
作者：
Joshua K. Elson
Jennifer L. Beebe-Dimmer
Hal Morgenstern
Mahdavi Chilkuri
John Blanchard
Alex B. Lentsch
机构：
[1] University of Michigan School of Public Health,Department of Epidemiology
[2] Wayne State University School of Medicine,Karmanos Cancer Institute and Department of Internal Medicine
[3] University of Michigan,Department of Environmental Health Sciences, School of Public Health and Comprehensive Cancer Center
[4] South East Regional Health Authority,Department of Surgery
[5] University of Cincinnati,undefined
来源：
Journal of Immigrant and Minority Health | 2011年 / 13卷
关键词：
Prostate cancer; DARC; African descent; Epidemiology; Chemokine receptors; Erythrocytes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
As an evolutionary response to prevent malaria infection, most Africans do not express the Duffy Antigen/Receptor for Chemokines (DARC) on their red blood cells. Results from experimental studies suggest that DARC expression inhibits prostate-tumor growth. We tested the hypothesis that men of African descent who lack DARC expression are at increased risk of prostate cancer. A case–control study involving 81 age-matched pairs was conducted in Jamaica. Participants were interviewed to collect data, and they donated blood for determination of DARC expression. Logistic regression was used to estimate associations with prostate cancer and aggressive disease. Little or no association was observed between erythrocyte DARC expression and prostate cancer or between DARC expression and aggressive disease. These associations changed little when adjusting for other potential confounders. Our results do not support an effect of erythrocyte DARC expression on the risk or progression of prostate cancer in men of African descent.
引用
收藏
页码：36 / 41
页数：5
相关论文
共 114 条
  • [1] Jemal A(2008)Cancer statistics, 2008 CA Cancer J Clin 58 71-96
  • [2] Siegel R(2001)Trends and patterns of prostate cancer: what do they suggest? Epidemiol Rev 23 3-13
  • [3] Ward E(2003)Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis Int J Cancer 107 797-803
  • [4] Hao Y(2002)Cancer statistics in African Americans Cancer J Clin 52 322-325
  • [5] Xu J(1998)The epidemiology of prostate cancer in Jamaica J Urol 159 1984-1986
  • [6] Murray T(2006)The duffy antigen/receptor for chemokines (DARC) regulates prostate cancer growth FASEB J 20 59-64
  • [7] Thun M(1997)From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen Blood 89 3077-3091
  • [8] Hsing A(1995)Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor J Biol Chem 270 25348-25351
  • [9] Devesa S(2000)The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ chemokine-induced angiogenic activity J Immunol 165 52669-52677
  • [10] Bruner D(1995)The functional role of the ELR motif in CXC chemokine-mediated angiogensis J Biol Chem 270 27348-27357
12345678910